1 / 103

VIRAL INFECTIONS

VIRAL INFECTIONS. Part II. IHAB YOUNIS, MD. Herpes simplex. Etiology. HSV(types 1&2) is a double-stranded DNA virus Characterized by: 1-Neurovirulence:the capacity to invade and replicate in nerves 2-Latency: latent infection in sensory nerve

karma
Download Presentation

VIRAL INFECTIONS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. VIRAL INFECTIONS Part II IHAB YOUNIS, MD

  2. Herpes simplex

  3. Etiology • HSV(types 1&2) is a double-stranded DNA virus • Characterized by: 1-Neurovirulence:the capacity to invade and replicate in nerves 2-Latency: latent infection in sensory nerve ganglia 3-Reactivation:induced by a variety of stimuli (eg, fever, trauma, emotional stress, sunlight, menstruation)

  4. Clinically 1- Acute herpetic gingivostomatitis • Occurs in children aged 6 months to 5 years • Mode of infection: Infected saliva from an adult or another child • The incubation period : 3-6 days

  5. Abrupt onset ,high temperature, anorexia and listlessness • Gingivitis: swollen, erythematous, friable gums • Vesicular lesions: on the oral mucosa, tongue, lips and later rupture and coalesce, leaving ulcerated plaques • Tender regional lymphadenopathy • Perioral skin also may be involved because of contamination with infected saliva

  6. Course • Acute disease lasts 5-7 days • Symptoms subside in 2 weeks • Viral shedding from the saliva may continue for 3 weeks or more

  7. 2-Acute herpetic pharyngotonsillitis • In adults, oropharyngeal HSV-1 causes pharyngitis and tonsillitis more often than gingivostomatitis • Fever, malaise, headache and sore throat • Vesicles rupture to form ulcerative lesions with grayish exudates on the tonsils& posterior pharynx • Less than10% have associated oral & labial lesions • HSV-2 can cause similar symptoms and is associated with orogenital contact or can occur concurrently with genital herpes

  8. 3-Recurrent Herpes labialis • A prodrome of pain, burning & tingling • Followed by the development of erythematous papules that rapidly develop into tiny, thin-walled, intraepidermal vesicles that become pustular and ulcerate • In most patients, fewer than 2 recurrences each year, but some individuals have monthly recurrences • Maximum viral shedding is in the first 24 hours of the acute illness but may last 5 days.

  9. 4-Primary genital herpes • Primary genital herpes can be caused by both HSV-1 and HSV-2 • Recurrences are more common with HSV-2 • Asymptomatic in most patients • Primary genital herpes is characterized by severe and prolonged systemic and local symptoms. The symptoms of persons with a first episode of nonprimary HSV-2 infection are less severe and of shorter duration • Preexisting antibodies to HSV-1 have an ameliorating effect on disease severity caused by HSV-2 • Prior orolabial HSV-1 protects against genital HSV-1 but not HSV-2 • Women's symptoms are more severe and women have a higher rate of complications than men

  10. Clinical features in men • Herpetic vesicles appear in the glans penis, the prepuce, the shaft of the penis, and sometimes on the scrotum, thighs, and buttocks • In dry areas, the lesions progress to pustules and then crust • Herpetic urethritis occurs in 30-40% of patients and is characterized by severe dysuria and mucoid discharge • The perianal area and rectum can be involved in persons who engage in anal intercourse, resulting in herpetic proctitis.

  11. Clinical features in women • Herpetic vesicles appear on the external genitalia, labia majora, labia minora, vaginal vestibule, and introitus • In moist areas, the vesicles rupture, leaving exquisitely tender ulcers • The vaginal mucosa is inflamed and edematous. The cervix may be involved in 70-90% of patients • Dysuria may be very severe and may cause urinary retention

  12. In men and women, the ulcerative lesions persist from 4-15 days until crusting and reepithelialization occur • The median duration of viral shedding is about 12 days.

  13. 5-Recurrent genital herpes • 60% of patients with 1ry genital HSV-2 have recurrences in the 1st year • 38% had 6 recurrences/year and 20% had more than 10 recurrences • Both subclinical and symptomatic reactivation are more common with HSV-2 compared to HSV-1 • Recurrent genital herpes is preceded by a prodrome of tenderness, pain, and burning at the site of eruption that may last from 2 hours to 2 days • Pain is mild, and lesions heal in 7-10 days and constitutional symptoms are uncommon. The lesions heal in 8-10 days and viral shedding lasts an average 5 days • The symptoms are more severe in women than men

  14. Subclinical genital herpes • The majority of primary genital HSV infections are asymptomatic and 70%-80% of seropositive individuals have no history of symptomatic genital herpes Nevertheless, they experience periodic subclinical reactivation with virus shedding, thus making them a source of infection • The rate of viral shedding may be 1-2% . This fact is important in neonatal herpes because most mothers have no signs and symptoms of genital herpes during pregnancy

  15. Histopathology • Epidermal spongiosis • Intraepidermal vesicle formation • Dermal inflammatory infilt

  16. Investigations • HSV infection is best confirmed by isolation of virus in tissue culture • Immunofluorescent staining of the tissue culture cells can quickly identify HSV and can distinguish between types 1 and 2 • Rapid detection of HSV DNA in clinical specimens is now possible with polymerase chain reaction (PCR)

  17. Antibody testing can demonstrate a primary seroconversion, particularly with HSV-1 in childhood • Because of sero–cross-reactivity, HSV-1 and HSV-2 are not generally distinguishable unless a glycoprotein G antibody assay is available • Antibody titer increases generally do not occur during recurrences of HSV.Therefore, the test generally is not used for the diagnosis of mucocutaneous HSV relapse

  18. Tzanck smear is a time-honored procedure to assist in the diagnosis of cutaneous herpesvirusinfections • Typically, an intact vesicle is used from which the vesicular fluid is aspirated • After aspiration, the vesicle should be unroofed aseptically.Using a sterile instrument, the floor of the newly produced ulcer can then be scraped. The obtained material can be spread on a glass microscope slide and then dried and fixed for staining

  19. Staining can be performed with a Papanicolaou stain,Gram or Giemsa • A positive result is the finding of multinucleate giant cells. • Using appropriate immunofluorescent antibody reagents, the smear can distinguish different herpesviruses and nonherpesviruses that may be present (eg, vaccinia, smallpox)

  20. Treatment • 1-Acyclovir (Acyclovir cream, zovirax, Lovir 400 mg tab)) • Inhibits the thymidine kinase of herpes viruses • Evidence from multiple clinical trials shows that topical acyclovir has little or no therapeutic effect

  21. Oral Dose: -First episode mucocutaneous herpes simplex: 400 mg tid for 7-10 d or until clinical resolution - Recurrent genital herpes: 200 mg PO five times daily for 5 d -Chronic suppressive therapy: 400 mg bid or 200 mg 3-5 times daily; reevaluate after 1 y

  22. 2-Valacyclovir (Valtrex): • Prodrug rapidly converted to the active drug acyclovir. More expensive but has a more convenient dosing regimen • Dose: -First episode: 1 g bid for 10 d -Recurrent episode : 500 mg bid for 5 d beginning within 24 h of onset -Suppressive dosing for HSV: 500 mg to 1 g/d

  23. 3-Famciclovir (Famvir) • Prodrug that when biotransformed into active metabolite, penciclovir • Inhibits viral DNA synthesis/replication • Dose: -Recurrent genital HSV: 125 mg bid for 5 d-Suppression of frequent recurrence of genital HSV: 250 mg bid up to 12 mo

  24. Eczema herpeticum

  25. Etiology • It is caused by a disseminated HSV infection in patients with atopic dermatitis • Patients have cell-mediated and humoral defects • A disorder of infants& children of any age • Occurs occasionally in adults

  26. Umbilicated vesiculopustules that progress to punched-out erosions • The eruption is most commonly disseminated in the areas of dermatitis, with a predilection for the head& trunk. Localized forms also exist • The vesicles often become hemorrhagic and crusted and can evolve into extremely painful erosions with a punched-out appearance • These erosions may coalesce to form large, denuded areas that frequently bleed and can become secondarily infected with bacteria

  27. The eruption continues to spread over 7-10 days and may be associated with a high temperature, malaise, and lymphadenopathy • Recurrent episodes may also occur but are milder and not usually associated with systemic symptoms

  28. Eczema herpeticum

  29. Treatment • Acyclovir IV or orally • Eczema treated as usual but steroids are used cautiously • Patients with atopic dermatitis should be aware of herpetic infection

  30. Herpes zoster (Shingles) Zoster=girdle

  31. Etiology • VZV is a double-stranded DNA virus • Infection initially produces chickenpox. Following resolution of the chickenpox, the virus lies dormant in the dorsal root ganglia until focal reactivation along a ganglion's distribution results in herpes zoster • Although the exact precipitants that result in viral reactivation are not known certainly, decreased cellular immunity appears to increase the risk of reactivation.

  32. Regarding primary infection, more than 90% of the population is infected by adolescence, and approximately 100% are infected by 60 years of age • Herpes zoster affects about 10-20% of the population

  33. Clinically • A prodrome (pain,fever, malaise, headache, and dysesthesia) occurs 1-4 days before the development of the cutaneous lesions • Grouped vesicles, usually involving 1, but occasionally up to 3, adjacent dermatomes • Vesicles become pustular, and occasionally hemorrhagic, with evolution to crusts in 7-10 days

  34. Pain may subside in 2-3 w in young patients but may last for 1 m in the elderly • Pain lasting longer than 1-3 months is referred to as postherpetic neuralgia. It affects 10-15% • Its incidence & severity increase with age • Types: -Continuous burnning with allodynia -Spasmodic shooting -Crawling pruritus

  35. Herpes zoster ophthalmicus • Vesicular rashes involving the ophthalmic division of the trigeminal nerve. Crusting begins on the fifth to sixth day • Hutchinson sign: severe ocular complications can occur with a vesicular rash anywhere on the forehead • Herpes zoster oticus • Vesicles involve the external auditory canal, concha, and pinna, postauricular skin, lateral nasal wall, soft palate, and anterolateral tongue • Vertigo and sensorineural hearing loss and/or paralysis of the facial nerve may be noted • Clinically, total loss of the ability to wrinkle the ipsilateral brow differentiates a peripheral seventh nerve lesion from a central seventh nerve lesion, which spares the forehead

  36. Treatment 1-Antivirals:should start within 1-2 d -Acyclovir 800 mg orally 5 times/d. for 7-10 d -Valacyclovir 1gm orally q8h for 7 d - Famciclovir (Famvir) 500 mg PO q8h for 7 d 2-Analgesics 3-?Prednisolone 60 mg/d orally tapered over 3 wk

  37. For postherpetic neuralgia: I- For stabing pain : Anticonvulsants: 1-Gabapentin (Neurontine,Gaptin,Conventine) 400-1200 mg orally 3 tds 2-Phenytoin (Dilantin)100 to 300 mg orally at bedtime; increase dosage until response is adequate 3-Carbamazepine (Tegretol)100-200 mg orally 1-3 times/day

  38. II- For burning pain :Tricyclic antidepressants: 1-Amitriptyline (Tryptizol 10mg Tab ) 25 mg orally tds 2-Imipramine (Tofranil 25 mg tab)25 mg orally 1-6 times/d

  39. Investigations • Tzanck smear • Biopsy is required for definitive diagnosis • PCR

  40. Immunologic tests for viral antigen • Direct immunofluorescence or immunoperoxidase stains • Radioimmunoassay • Enzyme-linked immunosorbent assay • Agar gel immunodiffusion • Immunoelectrophoresis

  41. Serology for VZV antibodies • Neutralizing or complement-fixing antibody tests • Enzyme-linked immunosorbent assay • Radioimmunoassay • Membrane antigen immunofluorescence • Immune adherence hemagglutination

  42. Chickenpox (Varicella)

  43. Etiology • The varicella-zoster virus enters through the respiratory system &by direct contact • The virus replicates in regional lymph nodes • After a week, a secondary viremia disseminates the virus to the viscera and skin • Varicella is highly contagious; secondary attack rates range from 80-90% for household contacts • Varicella's infectious period begins 2 days before skin lesions appear and ends when the lesions crust, usually 5 days later

  44. Clinically • Incubation period: 10-21 days • Prodrome : Low-grade fever, abdominal pain, cough and coryza preced skin manifestations by 1-2 days • Fever usually is low-grade and subsides within 4 days

  45. Rash • The characteristic rash appears in crops • There are 250-500 lesions but can be as few as 10 • Lesion starts as a red macule, rapidly develops into papule, vesicle, pustule and crust • Varicella's hallmark is the simultaneous presence of different stages of the rash • Rash is centripetal starting on the back • New lesions continue to erupt for 3-5 days, crust by 6 days and heal completely by 16 days

More Related